At a press briefing May 16, the American Society of Clinical Oncology announced the following studies will be presented at the 2019 ASCO Annual Meeting in Chicago:
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
